| 期 |
栏目 |
标题 |
文件 |
| 卷 82, 编号 6 (2010) |
Editorial |
Severe Wegener's granulomatosis successfully treated with rituximab |
|
| 卷 83, 编号 11 (2011) |
Editorial |
Experience with rituximab treatment (monoclonal antibodies to B-lymphocyte CD20 receptors) of Wegener's granulematosis patients with renal impairment |
|
| 卷 85, 编号 5 (2013) |
Editorial |
Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases |
|
| 卷 86, 编号 12-2 (2014) |
Editorial |
Поражение сердца при системных васкулитах: патогенетические звенья, значение факторов риска развития сердечно-сосудистых осложнений и диагностика |
|
| 卷 86, 编号 12-2 (2014) |
Editorial |
Giant cell arteritis as a cause of fever of unclear genesis in the elderly |
|
| 卷 87, 编号 6 (2015) |
Editorial |
Impact of interleukin-10 and interleukin-28 gene polymorphisms on the development and course of lupus nephritis |
|
| 卷 87, 编号 12 (2015) |
Editorial |
Ophthalmologic manifestations of granulomatosis with polyangiitis (Wegener’s granulomatosis) |
|
| 卷 89, 编号 5 (2017) |
Editorial |
Hepatitis C virus-associated cryoglobulinemic vasculitis: A 20-year experience with treatment |
(Rus)
|
| 卷 89, 编号 5 (2017) |
Editorial |
The frequency of ophthalmologic manifestations of granulomatosis with polyangiitis (Wegener’s) and their relationship to systemic diseases |
(Rus)
|
| 卷 89, 编号 8 (2017) |
Editorial |
Giant cell arteritis: Genetic and epigenetic aspects |
(Rus)
|
| 卷 90, 编号 1 (2018) |
Editorial |
The modern therapy of systemic vasculitides: perspectives and challenges |
(Rus)
|
| 卷 90, 编号 6 (2018) |
Editorial |
Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides |
(Rus)
|
| 卷 90, 编号 6 (2018) |
Editorial |
Clinical features of kidney involvement in microscopic microscopic polyangiitis |
(Rus)
|
